NuNaf Tablets

Spinin - C 25 mg Tablets (In motion sickness & balance disorders) Back

NuNaf Tablets

Composition:
Cinnarizine I.P. 25 mg
Excipients q.s.
Indication:
• Nausea
• Vomiting
• Motion sickness
• Inner Ear DisordersDescription:   

Cinnarizine, is approved for nausea, vomiting, motion sickness, inner ear disorder as first line pharmacotherapy for management of vertigo.

Cinnarizine shows multi modal mechanism of action.

  • Anti-vasoconstrictor activity
  • Decrease in blood viscosity
  • Calming of excited vestibular labyrinth

Dosage:
Use in adults: In balance disorders, brain blood circulation disorders and migraine prevention: 1 tablet, 3 times a day.
In blood circulation disorders in the arms or legs: 2 to 3 tablets 3 times a day.
In travel sickness: 1 tablet.

Presentation:
10 ml vial with dropper

Dosage:
Use in children and adolescents up to 18 years old: In travel sickness: 13 years and above: 1 tablet.
6 to 12 years ½ tablet.

© Copyright 2026. NuLife Pharmaceuticals. All Rights Reserved.